| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Median Arcuate Ligament Syndrome | 7 | 2023 | 23 | 2.840 |
Why?
|
| Peripheral Arterial Disease | 6 | 2024 | 92 | 1.900 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2015 | 138 | 1.530 |
Why?
|
| Abdominal Pain | 6 | 2023 | 139 | 1.450 |
Why?
|
| Celiac Artery | 4 | 2023 | 25 | 1.390 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2015 | 241 | 1.320 |
Why?
|
| Vascular Surgical Procedures | 8 | 2018 | 148 | 1.310 |
Why?
|
| Tunica Intima | 5 | 2015 | 60 | 1.210 |
Why?
|
| Blood Vessel Prosthesis Implantation | 14 | 2018 | 222 | 1.110 |
Why?
|
| Lower Extremity | 4 | 2024 | 87 | 1.060 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 218 | 1.030 |
Why?
|
| Carotid Stenosis | 7 | 2012 | 114 | 1.000 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2016 | 107 | 0.950 |
Why?
|
| Stents | 7 | 2018 | 390 | 0.940 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 257 | 0.920 |
Why?
|
| Herpesvirus 1, Human | 4 | 2015 | 244 | 0.890 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1639 | 0.810 |
Why?
|
| Carotid Artery, Internal | 4 | 2012 | 69 | 0.760 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 85 | 0.740 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2018 | 119 | 0.740 |
Why?
|
| Chronic Pain | 3 | 2018 | 159 | 0.720 |
Why?
|
| Endarterectomy, Carotid | 4 | 2012 | 74 | 0.720 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 96 | 0.620 |
Why?
|
| Mental Disorders | 2 | 2018 | 405 | 0.600 |
Why?
|
| Hyperplasia | 6 | 2015 | 151 | 0.600 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2019 | 42 | 0.580 |
Why?
|
| Apoptosis | 3 | 2008 | 1713 | 0.580 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 189 | 0.570 |
Why?
|
| Quality of Life | 4 | 2021 | 1645 | 0.550 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2013 | 61 | 0.530 |
Why?
|
| Laparoscopy | 4 | 2018 | 762 | 0.520 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2018 | 99 | 0.520 |
Why?
|
| Ligaments | 1 | 2013 | 33 | 0.460 |
Why?
|
| Rabbits | 9 | 2015 | 640 | 0.450 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 66 | 0.430 |
Why?
|
| Simplexvirus | 2 | 2012 | 151 | 0.430 |
Why?
|
| Aortic Diseases | 3 | 2009 | 99 | 0.420 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2012 | 39 | 0.410 |
Why?
|
| Mass Screening | 1 | 2016 | 631 | 0.400 |
Why?
|
| Male | 41 | 2024 | 41885 | 0.400 |
Why?
|
| Risk Factors | 10 | 2024 | 5434 | 0.400 |
Why?
|
| Iliac Artery | 2 | 2009 | 37 | 0.400 |
Why?
|
| Coronary Disease | 1 | 2013 | 261 | 0.400 |
Why?
|
| Humans | 52 | 2024 | 88354 | 0.390 |
Why?
|
| Coronary Vessels | 1 | 2013 | 190 | 0.390 |
Why?
|
| Leg | 5 | 2003 | 140 | 0.380 |
Why?
|
| Carotid Arteries | 1 | 2012 | 127 | 0.380 |
Why?
|
| Treatment Outcome | 18 | 2018 | 8135 | 0.370 |
Why?
|
| Aneurysm, False | 2 | 2007 | 55 | 0.360 |
Why?
|
| Angioplasty | 2 | 2007 | 70 | 0.350 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 22 | 0.330 |
Why?
|
| Veins | 5 | 2009 | 95 | 0.320 |
Why?
|
| Endoleak | 3 | 2019 | 41 | 0.310 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2018 | 239 | 0.310 |
Why?
|
| Calcinosis | 1 | 2009 | 230 | 0.310 |
Why?
|
| Aneurysm, Infected | 1 | 2007 | 12 | 0.310 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.300 |
Why?
|
| Exercise Therapy | 2 | 2018 | 80 | 0.300 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 73 | 0.290 |
Why?
|
| Retrospective Studies | 16 | 2024 | 8851 | 0.290 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2007 | 59 | 0.290 |
Why?
|
| Female | 30 | 2024 | 45612 | 0.280 |
Why?
|
| Aged | 22 | 2024 | 18875 | 0.280 |
Why?
|
| Middle Aged | 23 | 2024 | 25607 | 0.280 |
Why?
|
| Nicotine | 1 | 2008 | 199 | 0.270 |
Why?
|
| Hemodynamics | 5 | 2008 | 726 | 0.260 |
Why?
|
| Vascular Patency | 8 | 2009 | 126 | 0.260 |
Why?
|
| Time Factors | 11 | 2018 | 5301 | 0.250 |
Why?
|
| Adolescent | 8 | 2020 | 9131 | 0.250 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 155 | 0.240 |
Why?
|
| Thoracoscopy | 1 | 2003 | 23 | 0.230 |
Why?
|
| Thymectomy | 1 | 2003 | 31 | 0.230 |
Why?
|
| Genetic Vectors | 2 | 2003 | 443 | 0.230 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 6704 | 0.230 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 161 | 0.230 |
Why?
|
| Treatment Failure | 1 | 2024 | 289 | 0.230 |
Why?
|
| Myasthenia Gravis | 1 | 2003 | 83 | 0.220 |
Why?
|
| Ischemia | 5 | 2009 | 251 | 0.220 |
Why?
|
| Saphenous Vein | 5 | 2002 | 61 | 0.220 |
Why?
|
| Risk Assessment | 3 | 2024 | 2285 | 0.210 |
Why?
|
| Blood Flow Velocity | 6 | 2019 | 199 | 0.210 |
Why?
|
| Reoperation | 4 | 2013 | 605 | 0.210 |
Why?
|
| Logistic Models | 2 | 2024 | 1204 | 0.200 |
Why?
|
| Comorbidity | 4 | 2018 | 944 | 0.200 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 51 | 0.200 |
Why?
|
| Limb Salvage | 3 | 2009 | 33 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2013 | 398 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2013 | 2631 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 28 | 0.180 |
Why?
|
| Walking | 2 | 2018 | 89 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2020 | 65 | 0.180 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 166 | 0.170 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 81 | 0.170 |
Why?
|
| Genetic Therapy | 1 | 2001 | 357 | 0.170 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 144 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 3652 | 0.160 |
Why?
|
| Cost of Illness | 2 | 2018 | 148 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 38 | 0.160 |
Why?
|
| Child | 4 | 2018 | 7076 | 0.160 |
Why?
|
| Home Nursing | 1 | 2018 | 19 | 0.160 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 67 | 0.160 |
Why?
|
| Wearable Electronic Devices | 1 | 2018 | 25 | 0.150 |
Why?
|
| Caspase 3 | 2 | 2008 | 161 | 0.150 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 112 | 0.150 |
Why?
|
| Femoral Artery | 3 | 2009 | 83 | 0.150 |
Why?
|
| Mental Health | 1 | 2018 | 174 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 135 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2018 | 328 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 861 | 0.140 |
Why?
|
| Regional Blood Flow | 4 | 2018 | 198 | 0.140 |
Why?
|
| Thrombosis | 2 | 2014 | 301 | 0.140 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 360 | 0.140 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 28 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 2 | 2006 | 52 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 849 | 0.130 |
Why?
|
| Stress, Mechanical | 3 | 2008 | 250 | 0.130 |
Why?
|
| Animals | 10 | 2015 | 27129 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2018 | 4262 | 0.130 |
Why?
|
| Adult | 10 | 2018 | 26257 | 0.120 |
Why?
|
| Carotid Artery, Common | 3 | 2008 | 28 | 0.120 |
Why?
|
| Enteric Nervous System | 1 | 2013 | 8 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 858 | 0.120 |
Why?
|
| Diaphragm | 1 | 2013 | 50 | 0.110 |
Why?
|
| Jugular Veins | 3 | 2005 | 74 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2013 | 172 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2013 | 122 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 123 | 0.110 |
Why?
|
| Mutation | 4 | 2012 | 4092 | 0.110 |
Why?
|
| Leptospirosis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pediatrics | 1 | 2016 | 351 | 0.100 |
Why?
|
| Radiography | 4 | 2007 | 806 | 0.100 |
Why?
|
| Vascular Resistance | 2 | 2002 | 102 | 0.100 |
Why?
|
| Hemostatics | 1 | 2012 | 56 | 0.100 |
Why?
|
| Disease Progression | 2 | 2015 | 1488 | 0.100 |
Why?
|
| Aortography | 2 | 2009 | 64 | 0.100 |
Why?
|
| Cell Movement | 1 | 2015 | 783 | 0.100 |
Why?
|
| Lumbosacral Plexus | 1 | 2011 | 9 | 0.100 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 17 | 0.100 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 255 | 0.100 |
Why?
|
| Young Adult | 3 | 2018 | 6179 | 0.100 |
Why?
|
| ras Proteins | 1 | 2012 | 130 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2011 | 34 | 0.100 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 45 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 154 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 47 | 0.090 |
Why?
|
| Carotid Artery, External | 2 | 2008 | 8 | 0.090 |
Why?
|
| Research Design | 1 | 2014 | 594 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 460 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2013 | 946 | 0.090 |
Why?
|
| Environment | 1 | 2012 | 224 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2873 | 0.090 |
Why?
|
| Atherectomy | 1 | 2009 | 4 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 994 | 0.090 |
Why?
|
| Rupture | 1 | 2009 | 61 | 0.090 |
Why?
|
| Shear Strength | 1 | 2008 | 18 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 122 | 0.080 |
Why?
|
| Recurrence | 2 | 2002 | 1168 | 0.080 |
Why?
|
| Popliteal Artery | 2 | 2006 | 28 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 1704 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 3 | 2002 | 74 | 0.080 |
Why?
|
| Ligation | 1 | 2007 | 51 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 2007 | 35 | 0.080 |
Why?
|
| Cell Line | 1 | 2012 | 2497 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 266 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 797 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 122 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 87 | 0.070 |
Why?
|
| Brachiocephalic Trunk | 1 | 2006 | 14 | 0.070 |
Why?
|
| Survival Analysis | 4 | 2003 | 1542 | 0.070 |
Why?
|
| Arteries | 1 | 2007 | 180 | 0.070 |
Why?
|
| Homeostasis | 1 | 2008 | 407 | 0.070 |
Why?
|
| Robotics | 1 | 2008 | 268 | 0.060 |
Why?
|
| Pulsatile Flow | 2 | 2001 | 50 | 0.060 |
Why?
|
| Smoking | 1 | 2008 | 617 | 0.060 |
Why?
|
| Models, Animal | 2 | 2001 | 276 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 976 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2002 | 30 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2003 | 22 | 0.050 |
Why?
|
| Viscera | 1 | 2002 | 17 | 0.050 |
Why?
|
| Iliac Aneurysm | 1 | 2002 | 8 | 0.050 |
Why?
|
| Radial Artery | 1 | 2002 | 33 | 0.050 |
Why?
|
| Embolism | 1 | 2002 | 32 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 104 | 0.050 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 12 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2018 | 291 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 117 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 98 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 226 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 135 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 698 | 0.050 |
Why?
|
| Hemorheology | 1 | 2001 | 8 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2012 | 3360 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 112 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2002 | 230 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 152 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2020 | 61 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2002 | 891 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1847 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 412 | 0.040 |
Why?
|
| Heart Rate | 1 | 2002 | 492 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2001 | 235 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 303 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 912 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2001 | 252 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2000 | 107 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 1061 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 80 | 0.040 |
Why?
|
| Chicago | 3 | 2015 | 1407 | 0.040 |
Why?
|
| Biomarkers | 2 | 2015 | 1754 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 108 | 0.040 |
Why?
|
| Telephone | 1 | 2018 | 35 | 0.040 |
Why?
|
| Intermittent Claudication | 1 | 2017 | 20 | 0.040 |
Why?
|
| Walk Test | 1 | 2017 | 23 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 358 | 0.040 |
Why?
|
| Pressure | 3 | 2002 | 166 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 162 | 0.040 |
Why?
|
| Analgesics | 1 | 2018 | 119 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2586 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 289 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2018 | 227 | 0.040 |
Why?
|
| Self Report | 1 | 2018 | 294 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 491 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1841 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 272 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2019 | 0.030 |
Why?
|
| Telemedicine | 1 | 2018 | 179 | 0.030 |
Why?
|
| Stem Cells | 1 | 2017 | 368 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2002 | 2276 | 0.030 |
Why?
|
| Rupture, Spontaneous | 2 | 2006 | 43 | 0.030 |
Why?
|
| Hospitalization | 1 | 2000 | 869 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 752 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1709 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 729 | 0.030 |
Why?
|
| American Samoa | 1 | 2012 | 1 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 23 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 55 | 0.030 |
Why?
|
| Back Pain | 1 | 2011 | 42 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 69 | 0.020 |
Why?
|
| Constipation | 1 | 2011 | 63 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 685 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3746 | 0.020 |
Why?
|
| Length of Stay | 2 | 2002 | 726 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 98 | 0.020 |
Why?
|
| Critical Illness | 1 | 2009 | 304 | 0.020 |
Why?
|
| Vascular Fistula | 1 | 2006 | 12 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 208 | 0.020 |
Why?
|
| Respiratory Tract Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1687 | 0.020 |
Why?
|
| Tracheal Diseases | 1 | 2006 | 13 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2006 | 43 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2333 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2003 | 2832 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 773 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2743 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 153 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 170 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2003 | 17 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 166 | 0.010 |
Why?
|
| Inguinal Canal | 1 | 2003 | 6 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2002 | 12 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 107 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2003 | 44 | 0.010 |
Why?
|
| Rheology | 1 | 2002 | 39 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 250 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 147 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1019 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 126 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 17 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2002 | 39 | 0.010 |
Why?
|
| Time | 1 | 2002 | 77 | 0.010 |
Why?
|
| Femoral Vein | 1 | 2002 | 39 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2002 | 59 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 231 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 199 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 235 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 226 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 995 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2002 | 223 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 266 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 433 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 980 | 0.010 |
Why?
|
| Life Tables | 1 | 2000 | 48 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2002 | 251 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 271 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 381 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 349 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 696 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 155 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 465 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 901 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2000 | 340 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 770 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3429 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1881 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 909 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1787 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2257 | 0.010 |
Why?
|
| Hypertension | 1 | 2001 | 730 | 0.010 |
Why?
|